Product Code:284599
Published Date: Jan 15,2022
Pages: 107
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
As the global economy mends, the 2021 growth of Psoriatic Arthritis Therapeutics Drug will have significant change from previous year. According to our (LP Information) latest study, the global Psoriatic Arthritis Therapeutics Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Psoriatic Arthritis Therapeutics Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period. The United States Psoriatic Arthritis Therapeutics Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Psoriatic Arthritis Therapeutics Drug market, reaching US$ million by the year 2028. As for the Europe Psoriatic Arthritis Therapeutics Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period. Global main Psoriatic Arthritis Therapeutics Drug players cover AbbVie, Janssen Biotech, Novartis, and Amgen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021. This report presents a comprehensive overview, market shares, and growth opportunities of Psoriatic Arthritis Therapeutics Drug market by product type, application, key manufacturers and key regions and countries. Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6 NF Inhibitors Interleukin Inhibitors PDE4 Inhibitors Others Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7. Hospital Pharmacies Retail Pharmacies Online Pharmacies This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include AbbVie Janssen Biotech Novartis Amgen CELGENE CORPORATION Pfizer Eli Lilly UCB Biogen Bristol-Myers Squibb
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Psoriatic Arthritis Therapeutics Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Psoriatic Arthritis Therapeutics Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Psoriatic Arthritis Therapeutics Drug by Country/Region, 2017, 2022 & 2028
2.2 Psoriatic Arthritis Therapeutics Drug Segment by Type
2.2.1 NF Inhibitors
2.2.2 Interleukin Inhibitors
2.2.3 PDE4 Inhibitors
2.2.4 Others
2.3 Psoriatic Arthritis Therapeutics Drug Sales by Type
2.3.1 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Type (2017-2022)
2.4 Psoriatic Arthritis Therapeutics Drug Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Psoriatic Arthritis Therapeutics Drug Sales by Application
2.5.1 Global Psoriatic Arthritis Therapeutics Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Application (2017-2022)
3 Global Psoriatic Arthritis Therapeutics Drug by Company
3.1 Global Psoriatic Arthritis Therapeutics Drug Breakdown Data by Company
3.1.1 Global Psoriatic Arthritis Therapeutics Drug Annual Sales by Company (2020-2022)
3.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Company (2020-2022)
3.2 Global Psoriatic Arthritis Therapeutics Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Company (2020-2022)
3.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Company (2020-2022)
3.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Company
3.4 Key Manufacturers Psoriatic Arthritis Therapeutics Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Psoriatic Arthritis Therapeutics Drug Product Location Distribution
3.4.2 Players Psoriatic Arthritis Therapeutics Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Psoriatic Arthritis Therapeutics Drug by Geographic Region
4.1 World Historic Psoriatic Arthritis Therapeutics Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Psoriatic Arthritis Therapeutics Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Psoriatic Arthritis Therapeutics Drug Annual Revenue by Geographic Region
4.2 World Historic Psoriatic Arthritis Therapeutics Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Psoriatic Arthritis Therapeutics Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Psoriatic Arthritis Therapeutics Drug Annual Revenue by Country/Region
4.3 Americas Psoriatic Arthritis Therapeutics Drug Sales Growth
4.4 APAC Psoriatic Arthritis Therapeutics Drug Sales Growth
4.5 Europe Psoriatic Arthritis Therapeutics Drug Sales Growth
4.6 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Growth
5 Americas
5.1 Americas Psoriatic Arthritis Therapeutics Drug Sales by Country
5.1.1 Americas Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022)
5.1.2 Americas Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022)
5.2 Americas Psoriatic Arthritis Therapeutics Drug Sales by Type
5.3 Americas Psoriatic Arthritis Therapeutics Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriatic Arthritis Therapeutics Drug Sales by Region
6.1.1 APAC Psoriatic Arthritis Therapeutics Drug Sales by Region (2017-2022)
6.1.2 APAC Psoriatic Arthritis Therapeutics Drug Revenue by Region (2017-2022)
6.2 APAC Psoriatic Arthritis Therapeutics Drug Sales by Type
6.3 APAC Psoriatic Arthritis Therapeutics Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Psoriatic Arthritis Therapeutics Drug by Country
7.1.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022)
7.1.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022)
7.2 Europe Psoriatic Arthritis Therapeutics Drug Sales by Type
7.3 Europe Psoriatic Arthritis Therapeutics Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug by Country
8.1.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Type
8.3 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Psoriatic Arthritis Therapeutics Drug
10.3 Manufacturing Process Analysis of Psoriatic Arthritis Therapeutics Drug
10.4 Industry Chain Structure of Psoriatic Arthritis Therapeutics Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Psoriatic Arthritis Therapeutics Drug Distributors
11.3 Psoriatic Arthritis Therapeutics Drug Customer
12 World Forecast Review for Psoriatic Arthritis Therapeutics Drug by Geographic Region
12.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Region
12.1.1 Global Psoriatic Arthritis Therapeutics Drug Forecast by Region (2023-2028)
12.1.2 Global Psoriatic Arthritis Therapeutics Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Psoriatic Arthritis Therapeutics Drug Forecast by Type
12.7 Global Psoriatic Arthritis Therapeutics Drug Forecast by Application
13 Key Players Analysis
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Psoriatic Arthritis Therapeutics Drug Product Offered
13.1.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Janssen Biotech
13.2.1 Janssen Biotech Company Information
13.2.2 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Offered
13.2.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Janssen Biotech Main Business Overview
13.2.5 Janssen Biotech Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Psoriatic Arthritis Therapeutics Drug Product Offered
13.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Amgen
13.4.1 Amgen Company Information
13.4.2 Amgen Psoriatic Arthritis Therapeutics Drug Product Offered
13.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Amgen Main Business Overview
13.4.5 Amgen Latest Developments
13.5 CELGENE CORPORATION
13.5.1 CELGENE CORPORATION Company Information
13.5.2 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Offered
13.5.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 CELGENE CORPORATION Main Business Overview
13.5.5 CELGENE CORPORATION Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Psoriatic Arthritis Therapeutics Drug Product Offered
13.6.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Eli Lilly
13.7.1 Eli Lilly Company Information
13.7.2 Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Offered
13.7.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Eli Lilly Main Business Overview
13.7.5 Eli Lilly Latest Developments
13.8 UCB
13.8.1 UCB Company Information
13.8.2 UCB Psoriatic Arthritis Therapeutics Drug Product Offered
13.8.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 UCB Main Business Overview
13.8.5 UCB Latest Developments
13.9 Biogen
13.9.1 Biogen Company Information
13.9.2 Biogen Psoriatic Arthritis Therapeutics Drug Product Offered
13.9.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Biogen Main Business Overview
13.9.5 Biogen Latest Developments
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Information
13.10.2 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Offered
13.10.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Bristol-Myers Squibb Main Business Overview
13.10.5 Bristol-Myers Squibb Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Psoriatic Arthritis Therapeutics Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Psoriatic Arthritis Therapeutics Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of NF Inhibitors Table 4. Major Players of Interleukin Inhibitors Table 5. Major Players of PDE4 Inhibitors Table 6. Major Players of Others Table 7. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units) Table 8. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022) Table 9. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2017-2022) & ($ million) Table 10. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2017-2022) Table 11. Global Psoriatic Arthritis Therapeutics Drug Sale Price by Type (2017-2022) & (USD/Unit) Table 12. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units) Table 13. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022) Table 14. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2017-2022) Table 15. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2017-2022) Table 16. Global Psoriatic Arthritis Therapeutics Drug Sale Price by Application (2017-2022) & (USD/Unit) Table 17. Global Psoriatic Arthritis Therapeutics Drug Sales by Company (2020-2022) & (K Units) Table 18. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Company (2020-2022) Table 19. Global Psoriatic Arthritis Therapeutics Drug Revenue by Company (2020-2022) ($ Millions) Table 20. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Company (2020-2022) Table 21. Global Psoriatic Arthritis Therapeutics Drug Sale Price by Company (2020-2022) & (USD/Unit) Table 22. Key Manufacturers Psoriatic Arthritis Therapeutics Drug Producing Area Distribution and Sales Area Table 23. Players Psoriatic Arthritis Therapeutics Drug Products Offered Table 24. Psoriatic Arthritis Therapeutics Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 25. New Products and Potential Entrants Table 26. Mergers & Acquisitions, Expansion Table 27. Global Psoriatic Arthritis Therapeutics Drug Sales by Geographic Region (2017-2022) & (K Units) Table 28. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share Geographic Region (2017-2022) Table 29. Global Psoriatic Arthritis Therapeutics Drug Revenue by Geographic Region (2017-2022) & ($ millions) Table 30. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Geographic Region (2017-2022) Table 31. Global Psoriatic Arthritis Therapeutics Drug Sales by Country/Region (2017-2022) & (K Units) Table 32. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country/Region (2017-2022) Table 33. Global Psoriatic Arthritis Therapeutics Drug Revenue by Country/Region (2017-2022) & ($ millions) Table 34. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country/Region (2017-2022) Table 35. Americas Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022) & (K Units) Table 36. Americas Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2017-2022) Table 37. Americas Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022) & ($ Millions) Table 38. Americas Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2017-2022) Table 39. Americas Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units) Table 40. Americas Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022) Table 41. Americas Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units) Table 42. Americas Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022) Table 43. APAC Psoriatic Arthritis Therapeutics Drug Sales by Region (2017-2022) & (K Units) Table 44. APAC Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2017-2022) Table 45. APAC Psoriatic Arthritis Therapeutics Drug Revenue by Region (2017-2022) & ($ Millions) Table 46. APAC Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2017-2022) Table 47. APAC Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units) Table 48. APAC Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022) Table 49. APAC Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units) Table 50. APAC Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022) Table 51. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022) & (K Units) Table 52. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2017-2022) Table 53. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022) & ($ Millions) Table 54. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2017-2022) Table 55. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units) Table 56. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022) Table 57. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units) Table 58. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022) Table 59. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2017-2022) & (K Units) Table 60. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2017-2022) Table 61. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2017-2022) & ($ Millions) Table 62. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2017-2022) Table 63. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Type (2017-2022) & (K Units) Table 64. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2017-2022) Table 65. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Application (2017-2022) & (K Units) Table 66. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022) Table 67. Key Market Drivers & Growth Opportunities of Psoriatic Arthritis Therapeutics Drug Table 68. Key Market Challenges & Risks of Psoriatic Arthritis Therapeutics Drug Table 69. Key Industry Trends of Psoriatic Arthritis Therapeutics Drug Table 70. Psoriatic Arthritis Therapeutics Drug Raw Material Table 71. Key Suppliers of Raw Materials Table 72. Psoriatic Arthritis Therapeutics Drug Distributors List Table 73. Psoriatic Arthritis Therapeutics Drug Customer List Table 74. Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Region (2023-2028) & (K Units) Table 75. Global Psoriatic Arthritis Therapeutics Drug Sales Market Forecast by Region Table 76. Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Region (2023-2028) & ($ millions) Table 77. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share Forecast by Region (2023-2028) Table 78. Americas Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2023-2028) & (K Units) Table 79. Americas Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2023-2028) & ($ millions) Table 80. APAC Psoriatic Arthritis Therapeutics Drug Sales Forecast by Region (2023-2028) & (K Units) Table 81. APAC Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Region (2023-2028) & ($ millions) Table 82. Europe Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2023-2028) & (K Units) Table 83. Europe Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2023-2028) & (K Units) Table 85. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2023-2028) & ($ millions) Table 86. Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Type (2023-2028) & (K Units) Table 87. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share Forecast by Type (2023-2028) Table 88. Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Type (2023-2028) & ($ Millions) Table 89. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share Forecast by Type (2023-2028) Table 90. Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Application (2023-2028) & (K Units) Table 91. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share Forecast by Application (2023-2028) Table 92. Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Application (2023-2028) & ($ Millions) Table 93. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share Forecast by Application (2023-2028) Table 94. AbbVie Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors Table 95. AbbVie Psoriatic Arthritis Therapeutics Drug Product Offered Table 96. AbbVie Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 97. AbbVie Main Business Table 98. AbbVie Latest Developments Table 99. Janssen Biotech Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors Table 100. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Offered Table 101. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 102. Janssen Biotech Main Business Table 103. Janssen Biotech Latest Developments Table 104. Novartis Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors Table 105. Novartis Psoriatic Arthritis Therapeutics Drug Product Offered Table 106. Novartis Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 107. Novartis Main Business Table 108. Novartis Latest Developments Table 109. Amgen Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors Table 110. Amgen Psoriatic Arthritis Therapeutics Drug Product Offered Table 111. Amgen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 112. Amgen Main Business Table 113. Amgen Latest Developments Table 114. CELGENE CORPORATION Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors Table 115. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Offered Table 116. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 117. CELGENE CORPORATION Main Business Table 118. CELGENE CORPORATION Latest Developments Table 119. Pfizer Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors Table 120. Pfizer Psoriatic Arthritis Therapeutics Drug Product Offered Table 121. Pfizer Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 122. Pfizer Main Business Table 123. Pfizer Latest Developments Table 124. Eli Lilly Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors Table 125. Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Offered Table 126. Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 127. Eli Lilly Main Business Table 128. Eli Lilly Latest Developments Table 129. UCB Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors Table 130. UCB Psoriatic Arthritis Therapeutics Drug Product Offered Table 131. UCB Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 132. UCB Main Business Table 133. UCB Latest Developments Table 134. Biogen Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors Table 135. Biogen Psoriatic Arthritis Therapeutics Drug Product Offered Table 136. Biogen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 137. Biogen Main Business Table 138. Biogen Latest Developments Table 139. Bristol-Myers Squibb Basic Information, Psoriatic Arthritis Therapeutics Drug Manufacturing Base, Sales Area and Its Competitors Table 140. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Offered Table 141. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022) Table 142. Bristol-Myers Squibb Main Business Table 143. Bristol-Myers Squibb Latest Developments List of Figures Figure 1. Picture of Psoriatic Arthritis Therapeutics Drug Figure 2. Psoriatic Arthritis Therapeutics Drug Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2017-2028 (K Units) Figure 7. Global Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Psoriatic Arthritis Therapeutics Drug Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of NF Inhibitors Figure 10. Product Picture of Interleukin Inhibitors Figure 11. Product Picture of PDE4 Inhibitors Figure 12. Product Picture of Others Figure 13. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type in 2021 Figure 14. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2017-2022) Figure 15. Psoriatic Arthritis Therapeutics Drug Consumed in Hospital Pharmacies Figure 16. Global Psoriatic Arthritis Therapeutics Drug Market: Hospital Pharmacies (2017-2022) & (K Units) Figure 17. Psoriatic Arthritis Therapeutics Drug Consumed in Retail Pharmacies Figure 18. Global Psoriatic Arthritis Therapeutics Drug Market: Retail Pharmacies (2017-2022) & (K Units) Figure 19. Psoriatic Arthritis Therapeutics Drug Consumed in Online Pharmacies Figure 20. Global Psoriatic Arthritis Therapeutics Drug Market: Online Pharmacies (2017-2022) & (K Units) Figure 21. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2017-2022) Figure 22. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application in 2021 Figure 23. Psoriatic Arthritis Therapeutics Drug Revenue Market by Company in 2021 ($ Million) Figure 24. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Company in 2021 Figure 25. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Geographic Region (2017-2022) Figure 26. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Geographic Region in 2021 Figure 27. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2017-2022) Figure 28. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country/Region in 2021 Figure 29. Americas Psoriatic Arthritis Therapeutics Drug Sales 2017-2022 (K Units) Figure 30. Americas Psoriatic Arthritis Therapeutics Drug Revenue 2017-2022 ($ Millions) Figure 31. APAC Psoriatic Arthritis Therapeutics Drug Sales 2017-2022 (K Units) Figure 32. APAC Psoriatic Arthritis Therapeutics Drug Revenue 2017-2022 ($ Millions) Figure 33. Europe Psoriatic Arthritis Therapeutics Drug Sales 2017-2022 (K Units) Figure 34. Europe Psoriatic Arthritis Therapeutics Drug Revenue 2017-2022 ($ Millions) Figure 35. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales 2017-2022 (K Units) Figure 36. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue 2017-2022 ($ Millions) Figure 37. Americas Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2021 Figure 38. Americas Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2021 Figure 39. United States Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 40. Canada Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 41. Mexico Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 42. Brazil Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 43. APAC Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region in 2021 Figure 44. APAC Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Regions in 2021 Figure 45. China Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 46. Japan Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 47. South Korea Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 48. Southeast Asia Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 49. India Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 50. Australia Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 51. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2021 Figure 52. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2021 Figure 53. Germany Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 54. France Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 55. UK Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 56. Italy Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 57. Russia Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 58. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2021 Figure 59. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2021 Figure 60. Egypt Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 61. South Africa Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 62. Israel Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 63. Turkey Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 64. GCC Country Psoriatic Arthritis Therapeutics Drug Revenue Growth 2017-2022 ($ Millions) Figure 65. Manufacturing Cost Structure Analysis of Psoriatic Arthritis Therapeutics Drug in 2021 Figure 66. Manufacturing Process Analysis of Psoriatic Arthritis Therapeutics Drug Figure 67. Industry Chain Structure of Psoriatic Arthritis Therapeutics Drug Figure 68. Channels of Distribution Figure 69. Distributors Profiles
AbbVie Janssen Biotech Novartis Amgen CELGENE CORPORATION Pfizer Eli Lilly UCB Biogen Bristol-Myers Squibb
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape